Patent Term Extended Under 35 U.S.C. 156

  An interim extension of the term of U.S. Patent No. 4,085,225 has been
granted under 35 U.S.C. 156(e)(2) for a period of one year from the
original expiration date of the patent. An application for patent term
extension was filed by the patent owner of record Duphar International
Research B.V. based on approval of the product "LUVOX" by the Food and
Drug Administration.